Munronoid I Ameliorates DSS-Induced Mouse Colitis by Inhibiting NLRP3 Inflammasome Activation and Pyroptosis Via Modulation of NLRP3

X Ma, Q Di, X Li, X Zhao, R Zhang, Y Xiao, X Li… - Frontiers in …, 2022 - frontiersin.org
Inflammatory bowel diseases (IBDs) are increasingly common diseases characterized by
chronic and relapsing inflammation of the gastrointestinal tract. NLRP3 might be a crucial …

Oroxindin inhibits macrophage NLRP3 inflammasome activation in DSS-induced ulcerative colitis in mice via suppressing TXNIP-dependent NF-κB pathway

Q Liu, R Zuo, K Wang, F Nong, Y Fu, S Huang… - Acta Pharmacologica …, 2020 - nature.com
Oroxindin is a flavonoid isolated from the traditional Chinese medicine Huang-Qin, which
has shown various pharmacological activities including anti-inflammatory, antitumor …

[HTML][HTML] Flavonoid VI-16 protects against DSS-induced colitis by inhibiting Txnip-dependent NLRP3 inflammasome activation in macrophages via reducing oxidative …

Y Zhao, Q Guo, Q Zhu, R Tan, D Bai, X Bu, B Lin… - Mucosal …, 2019 - Elsevier
Emerging evidence suggests that NLRP3 inflammasome was associated with various kinds
of immunological diseases including colitis. However, there are few drugs targeting …

C646 protects against DSS-induced colitis model by targeting NLRP3 inflammasome

X Xu, J Li, X Long, S Tao, X Yu, X Ruan… - Frontiers in …, 2021 - frontiersin.org
Numerous pieces of evidence have identified that the NLRP3 inflammasome plays a pivotal
role in the development and pathogenesis of colitis. Targeting the NLRP3 inflammasome …

Wedelolactone facilitates Ser/Thr phosphorylation of NLRP3 dependent on PKA signalling to block inflammasome activation and pyroptosis

H Pan, Y Lin, J Dou, Z Fu, Y Yao, S Ye… - Cell …, 2020 - Wiley Online Library
Objectives Wedelolactone exhibits regulatory effects on some inflammatory diseases.
However, the anti‐inflammatory mechanism of wedelolactone has not been entirely …

BBG enhances OLT1177-induced NLRP3 inflammasome inactivation by targeting P2X7R/NLRP3 and MyD88/NF-κB signaling in DSS-induced colitis in rats

S Saber, ME Youssef, H Sharaf, NA Amin… - Life Sciences, 2021 - Elsevier
Chronic ulceration of the colon is associated with the activation of TLR4/NF-κB and
P2X7R/NLRP3 signaling pathways. We investigated the effect of individual or combined …

Picroside II alleviates DSS-induced ulcerative colitis by suppressing the production of NLRP3 inflammasomes through NF-κB signaling pathway

H Yao, J Yan, L Yin, W Chen - Immunopharmacology and …, 2022 - Taylor & Francis
Context Ulcerative colitis (UC) is a common acute or chronic intestinal disease with an
imbalance of inflammation. Picroside II (P-II) exerts a protective role in various inflammation …

Ononin alleviates DSS‐induced colitis through inhibiting NLRP3 inflammasome via triggering mitophagy

T Yu, X Lu, Y Liang, L Yang, Y Yin… - Immunity, Inflammation …, 2023 - Wiley Online Library
Background: Ononin, a flavonoid isolated from Astragalus membranaceus root, is the active
ingredient of A. membranaceus and has potential anti‐inflammatory properties, but its effect …

Norisoboldine, a natural aryl hydrocarbon receptor agonist, alleviates TNBS-induced colitis in mice, by inhibiting the activation of NLRP3 inflammasome

LV Qi, W Kai, Q Si-Miao, DAI Yue… - Chinese journal of natural …, 2018 - Elsevier
Although the etiology of inflammatory bowel disease is still uncertain, increasing evidence
indicates that the excessive activation of NLRP3 inflammasome plays a major role …

Coptisine attenuates post‑infectious IBS via Nrf2‑dependent inhibition of the NLPR3 inflammasome

Y Xiong, H Wei, C Chen, L Jiao… - Molecular …, 2022 - spandidos-publications.com
Inhibition of the activation of the NLR family pyrin domain‑containing 3 (NLRP3)
inflammasome has previously been reported to confer protection against post‑infectious …